AIM ImmunoTech Inc.
AIM
$9.21
$0.9110.96%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 51.13% | 40.20% | -15.18% | -44.98% | -61.35% |
| Total Depreciation and Amortization | -1.20% | 3.36% | -31.43% | -29.23% | -9.12% |
| Total Amortization of Deferred Charges | 300.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 148.83% | 387.42% | 156.11% | 102.73% | -5.64% |
| Change in Net Operating Assets | -95.80% | -95.85% | -55.06% | 98.50% | 553.86% |
| Cash from Operations | 44.50% | 29.99% | -17.71% | -37.79% | -31.54% |
| Capital Expenditure | -- | -- | 97.98% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -98.79% | -99.70% | -99.54% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 721.51% | 637.43% | 198.68% | 120.46% | -112.55% |
| Cash from Investing | 731.80% | 665.63% | -71.29% | -96.46% | -108.10% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 71.29% | 83.92% | 197.93% | 850.77% | 296.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.01% | 1,228.66% | 1,543.20% | 4,246.15% | 1,685.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.07% | 82.71% | 1.01% | -30.34% | -259.31% |